The Liver Care Trial

Condition(s) studied

Investigational drug(s) / intervention(s)

Transient Elastography: One transient elastography 1-2 weeks after randomization

Study summary

The goal of this clinical trial is to evaluate the efficacy of screening for liver disease with liver stiffness measurement on abstinence or light consumption after 6 months in individuals who are receiving treatment for alcohol use disorder and without a history of liver disease. The investigators will conduct a randomized controlled trial with concealed allocation comparing A) an invitation to a liver stiffness measurement, blood sampling and leaflet on alcohol-related disease (intervention) with B) an invitation to blood sampling (control). The primary outcome is 'abstinence or light consumption' (≤ 10 units/week) throughout the last months, and assessed 6 months after randomization.

Eligibility

Primary outcome measure(s)

• Alcohol abstinence or light consumption (≤ 10 units/week) the last 30 days (yes/no) assessed 6 months since randomization — Assessed 6 months after randomization
  Assessed By telephone interview or health record

Trial sites (2)

More Zealand University Hospital trials in Denmark

Other trials for the same condition